Condition: Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy · Sponsor: Zhongshan People's Hospital, Guangdong, China
This is a multi-center, non-inferiority, open-label, randomized controlled phase III clinical trial in primary diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. This study aims to compare the regional control, survival outcomes, radiation-related toxicities, and quality of life (QoL) of xerostomia-optimized intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in NPC patients
This description comes directly from the study's public registry record.
Gui-qiong Xu, MD · +8613528109888 · donna_shee@163.com
Always discuss trial participation with your own doctor first.
| Zhongshan City People's Hospital | Zhongshan, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06282497